Zhengye Biotechnology Holding Limited - Class A Ordinary Shares (ZYBT)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $379.6M
- P/E ratio
- —
- EPS
- —
- Volume
- 136,121,916
- 52-week high
- —
- 52-week low
- —
- Open
- $1.26
- Day high
- $8.01
- Day low
- $1.19
Financial highlights
Annual financials for Zhengye Biotechnology Holding Limited - Class A Ordinary Shares are being compiled and will appear here soon.
About Zhengye Biotechnology Holding Limited - Class A Ordinary Shares
Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.
- CEO
- Songlin Song
- Employees
- 269
- Country
- CN
- IPO date
- Jan 7, 2025
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Zhengye Biotechnology Holding Limited - Class A Ordinary Shares's stock price today?
- ZYBT is trading at $8.01 as of Jul 20, 2026.
- What is Zhengye Biotechnology Holding Limited - Class A Ordinary Shares's market cap?
- Zhengye Biotechnology Holding Limited - Class A Ordinary Shares (ZYBT) has a market capitalization of $379.6M.
- What sector is Zhengye Biotechnology Holding Limited - Class A Ordinary Shares in?
- Zhengye Biotechnology Holding Limited - Class A Ordinary Shares operates in the Healthcare sector.